Increased Release of Soluble Tumor Necrosis Factor Receptors Into Blood During Clinical Sepsis
- 1 December 1994
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 129 (12) , 1330-1337
- https://doi.org/10.1001/archsurg.1994.01420360120017
Abstract
Objectives: To examine the kinetics of altered soluble tumor necrosis factor receptors (sTNFRs) released in patients with severe sepsis, their correlation with the morbidity and mortality of these patients, and the role of endotoxin to induce cleavage of sTNFRs. Design: Soluble TNFR levels in plasma obtained from 40 patients with severe sepsis (mean [±SD] Acute Physiology and Chronic Health Evaluation [APACHE] II score, 27.9±7.0 points) on days 0, 1, 3, 5, and 10 after sepsis diagnosis were measured using specific enzyme-linked immunological binding assays and compared with levels in 75 control patients without infection. In addition, an ex vivo model consisting of lipopolysaccharide stimulation of human whole blood as a relevant physiological milieu was used. Blood from patients with sepsis and control patients was incubated in the presence or absence of lipopolysaccharide (1 mg/L) for 0, 1, 2, 4, 8, and 24 hours. Plasma levels of sTNFRs from both groups were determined using the enzyme-linked immunological binding assays. Results: In patients with sepsis, plasma levels of both sTNFRs were markedly (P<.01) increased during the whole observation period, compared with those of control patients, and correlated (P<.001) with the simultaneously obtained APACHE II and multiple organ failure scores, as well as with mortality. Although incubation of whole blood with lipopolysaccharide increased the release of sTNFR p55 and p75 in both groups, sTNFR concentrations in blood from control patients remained low compared with those of patients with severe sepsis, despite stimulation of whole blood with a maximum lipopolysaccharide concentration. Conclusions: These data indicate that an enhanced release of sTNFRs during severe sepsis is not solely induced by endotoxin. Since the degree of increased sTNFR levels portended poorly for patient survival, elevated sTNFR levels may represent a good marker for severity of sepsis, thus predicting outcome. (Arch Surg. 1994;129:1330-1337)Keywords
This publication has 11 references indexed in Scilit:
- Detection of Tumor Necrosis Factor Soluble Receptor p55 in Blood Samples from Healthy and Endotoxemic HumansThe Journal of Infectious Diseases, 1993
- TRAUMA CAUSES EARLY RELEASE OF SOLUBLE RECEPTORS FOR TUMOR NECROSIS FACTORPublished by Wolters Kluwer Health ,1993
- Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.Journal of Clinical Investigation, 1992
- Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptorsBiochemical and Biophysical Research Communications, 1992
- A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharideJournal of Immunological Methods, 1991
- Shedding of tumor necrosis factor receptors by activated human neutrophils.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor in the pathophysiology of infection and sepsisClinical Immunology and Immunopathology, 1990
- Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.Proceedings of the National Academy of Sciences, 1990
- Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.The Journal of Experimental Medicine, 1990
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985